National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 11/19/2021 release of VAERS data:

This is VAERS ID 1729157

Government Disclaimer on use of this data

Case Details

VAERS ID: 1729157 (history)  
Form: Version 2.0  
Sex: Female  
Location: Foreign  
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-09-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Other       Purchased by: ?
Symptoms: Chills, Fatigue, Headache, Lymphadenopathy, Myalgia, Nausea, Pyrexia, SARS-CoV-2 test, Tremor
SMQs:, Rhabdomyolysis/myopathy (broad), Acute pancreatitis (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Parkinson-like events (broad), Noninfectious encephalopathy/delirium (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Eosinophilic pneumonia (broad), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Paracetamol
Current Illness:
Preexisting Conditions:
Diagnostic Lab Data: Test Name: COVID-19 virus test; Result Unstructured Data: Test Result: No - Negative COVID-19 test.
CDC Split Type: GBPFIZER INC202101196430

Write-up: This is a spontaneous report from a contactable consumer (the patient), received via the regulatory authority (report number: GB-MHRA-WEBCOVID-202109121901312860-ZGDRY; safety report unique identifier: GB-MHRA-ADR 25929334). A female patient, of unspecified age, received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# FE3380), via an unspecified route of administration, on Sep 11, 2021, single dose, for COVID-19 immunisation. Medical history not reported. The patient did not have symptoms associated with COVID-19. Patient not enrolled in a clinical trial. Concomitant medications included paracetamol for an unknown indication from Sep 10, 2021 and unknown if ongoing. On Sep 11, 2021 (on the same day of vaccination), patient had swollen lymph nodes in the armpit where the patient received the vaccine. On an unknown date in Sep 2021, patient experienced shaking, severe headache, fever, nausea, fatigue, shivering and muscles pain; all the events reported serious (medically significant). On an unknown date, patient underwent a COVID-19 virus test: negative result. The patient has not tested positive for COVID-19 since the vaccination. The outcome of swollen lymph nodes in the armpit: not recovered; while that of severe headache, shivering, shaking, fatigue, fever, muscles pain and nausea: unknown (at the time of this report). No follow-up attempts needed. No further information expected.

New Search

Link To This Search Result:

Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166